Your browser doesn't support javascript.
loading
Peptide-guided nanoparticles for glioblastoma targeting.
Säälik, Pille; Lingasamy, Prakash; Toome, Kadri; Mastandrea, Ignacio; Rousso-Noori, Liat; Tobi, Allan; Simón-Gracia, Lorena; Hunt, Hedi; Paiste, Päärn; Kotamraju, Venkata Ramana; Bergers, Gabriele; Asser, Toomas; Rätsep, Tõnu; Ruoslahti, Erkki; Bjerkvig, Rolf; Friedmann-Morvinski, Dinorah; Teesalu, Tambet.
Afiliação
  • Säälik P; Laboratory of Cancer Biology, Institute of Biomedicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.
  • Lingasamy P; Laboratory of Cancer Biology, Institute of Biomedicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.
  • Toome K; Laboratory of Cancer Biology, Institute of Biomedicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.
  • Mastandrea I; Sagol School of Neuroscience, Department of Biochemistry and Molecular Biology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Israel.
  • Rousso-Noori L; Sagol School of Neuroscience, Department of Biochemistry and Molecular Biology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Israel.
  • Tobi A; Laboratory of Cancer Biology, Institute of Biomedicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.
  • Simón-Gracia L; Laboratory of Cancer Biology, Institute of Biomedicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.
  • Hunt H; Laboratory of Cancer Biology, Institute of Biomedicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.
  • Paiste P; Department of Geology, University of Tartu, Tartu, Estonia.
  • Kotamraju VR; Cancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
  • Bergers G; Laboratory for Tumor Microenvironment and Therapeutic Resistance, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
  • Asser T; Department of Neurosurgery, Tartu University Hospital, Tartu, Estonia.
  • Rätsep T; Department of Neurosurgery, Tartu University Hospital, Tartu, Estonia.
  • Ruoslahti E; Cancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA; Center for Nanomedicine and Department of Cell, Molecular and Developmental Biology, University of California Santa Barbara, Santa Barbara, CA, USA.
  • Bjerkvig R; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Friedmann-Morvinski D; Sagol School of Neuroscience, Department of Biochemistry and Molecular Biology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Israel. Electronic address: dino@tauex.tau.ac.il.
  • Teesalu T; Laboratory of Cancer Biology, Institute of Biomedicine, Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia; Cancer Research Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA; Center for Nanomedicine and Department of Cell, Molecul
J Control Release ; 308: 109-118, 2019 08 28.
Article em En | MEDLINE | ID: mdl-31255690
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Neoplasias Encefálicas / Sistemas de Liberação de Medicamentos / Glioblastoma / Nanopartículas Limite: Animals / Female / Humans / Male Idioma: En Revista: J Control Release Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Neoplasias Encefálicas / Sistemas de Liberação de Medicamentos / Glioblastoma / Nanopartículas Limite: Animals / Female / Humans / Male Idioma: En Revista: J Control Release Ano de publicação: 2019 Tipo de documento: Article